Menu Close

Articles on Johnson & Johnson

Displaying all articles

The concern is about more than one shot vs. two. Michael Ciaglo/Getty Images

Backlash against Johnson & Johnson’s COVID-19 vaccine is real and risky – here’s how to make its rollout a success

Religious opposition over a link to abortions performed decades ago and misunderstandings about effectiveness could lead to a nightmare of angry patients and wasted vaccine.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool. (Shutterstock)

Can a pharma company change? Profit, not altruism, motivates COVID-19 vaccine development

We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Johnson & Johnson was ordered to pay US$.4.69 billion in July, 2018 because it failed to warn customers that its baby powder contains asbestos. Matt Rourke/AP Photo

Why asbestos litigation won’t go away: Because asbestos won’t go away

Asbestos litigation is the number one source of tort claims in the US, with many people decrying the filing of so many claims. But there's a reason the claims persist. Asbestos isn't going anywhere.
Ron Barnes, Doug Cope, Eileen Webber and Bob Lugton feature in ABC TV’s 4 Corners documentary The Walking Wounded. The Walking Wounded, Four Corners

The Walking Wounded calls for a rethink of what we most value

Starting with Karl Marx, many thinkers have pointed out that the creative potential of the capitalist economic system comes at a cost – the lack of inherent ethical scruples to limit the inexorable logic…

Top contributors

More